Latest KDventures News & Updates

See the latest news and media coverage for KDventures. We track all announcements, press releases, and industry mentions in real time, all in one place.

KDventures

Life science investment company

kd-ventures.com

Headquarters: Solna, Sweden
Founded year: 2003
Company type: Public company
Number of employees: 2–25
Industry: Investment Holding Companies

Last updated Today

Latest news about KDventures

In short: KDventures rebranded from Karolinska Development, completed several capital raises, and reported clinical progress in its core portfolio.

Company announcements

July 9 KDventures

KDventures writes down PharmNovo holding after capital raise

PharmNovo raised SEK 39 million for phase 2 study of PN6047, and KDventures wrote down its holding to SEK 5 million.

June 25 KDventures

KDventures' portfolio company AnaCardio's study published in The Lancet

The phase 1b/2a study of drug candidate AC01 shows favorable safety and efficacy signals for heart failure patients.

June 17 KDventures

KDventures raised SEK 23.9 million via directed share issue

The proceeds will finance the acquisition of Rosetta Capital IV's shares in KDev Investments AB, announced on 17 June 2026.

June 8 KDventures

KDventures joins Umecrine Cognition share issue and writes down value

The write-down reduces book value by 65.5%, or SEK 390.1 million, with no cash flow impact.

Media coverage

June 24 The Globe and Mail

KDventures' Umecrine Cognition trial of golexanolone advances unchanged after interim analysis

An announcement from KDventures AB ( ($SE:KDV.B) ) is now available.

May 14 The Globe and Mail

KDventures Unit Flags Unmet Need in PBC as CNS Drug Golexanolone Advances

KDventures’ portfolio company Umecrine Cognition has reported new data showing that more than half of primary biliary cholangitis patients suffer severe central fatigue and cognitive...

April 9 FinanzNachrichten.de

KDventures AB: KDventures' portfolio company SVF Vaccines partners with Touchlight to accelerate SVF-001 toward clinical development

STOCKHOLM, Sweden, April 9, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company SVF Vaccines has entered into a collaboration with Touchlight...

April 6 MFN.se

MFN.se > KD Ventures > The shareholders in KDventures AB (publ) are invited to the annual general meeting

The shareholders in KDventures AB (publ), org. no. 556707-5048, (“KDventures” or “the Company”), are invited to the annual general meeting on Tuesday, May 12, 2026 at 15.00 at Nanna Svartz väg 2...

Never miss news about KDventures

Track KDventures and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

KDventures competitors & trending companies

Browse news for competitors to KDventures and other trending companies.